Casey Lnch is the founder of Cortexyme. Cortexyme has raised $92M in total funding. Latest round: Series B. Backed by Sequoia Capital, Pfizer.
Casey Lynch is the co-founder and CEO of Cortexyme, a biopharmaceutical company focused on developing therapeutics for Alzheimer's disease and other degenerative disorders. He has guided the company through significant funding rounds, including a $15 million Series A and a $76 million Series B.
Full founder directory · Investor directory · Company funding database · Fundraising library